GlassScriptPhysician profile
David Martin
NPI 1841721727
$7,629.24
in general payments reported to CMS, 2019-2025
10 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,590 · 2023: $2,890 · 2024: $654 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,751 · Travel and Lodging: $2,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.61 |
| Travel and Lodging | $2,288.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,687.39 | 2022-2025 | Mako, Blueprint Patient Specific Instrumentation, Axsos |
| Smith+Nephew, INC. | $2,611.17 | 2023-2025 | Ri Hip Navigation, Or3o Dual Mobility, Journey |
| Medacta USA, INC. | $935.66 | 2023-2025 | Amistem, Gmk Revision, Nextar Knee |
| Globus Medical, INC. | $240.20 | 2022-2023 | Signify, A/R Femoral Nail |
| Encore Medical, LP | $43.62 | 2022 | |
| Acera Surgical, INC. | $32.17 | 2024 | Restrata Wound Matrix |
| Acumed LLC | $24.70 | 2024 | Acumed |
| Heron Therapeutics, INC. | $19.70 | 2025 | Zynrelef |
| Microport Orthopedics INC | $17.58 | 2024 | Mpo Medial Pivot Knee |
| Exactech, INC. | $17.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.